Grufity logo
Grufity logo

Latest Lynx1 Capital Management LP Stock Portfolio

$865Million | No. of Holdings #27

Lynx1 Capital Management LP Performance

2026 Q2+31.32%
YTD+47.75%
2025+63.54%

About Lynx1 Capital Management LP and 13F Hedge Fund Stock Holdings

Lynx1 Capital Management LP is a hedge fund based in San Juan, PR. On 2026-08-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Lynx1 Capital Management LP reported an equity portfolio of $865.5 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Lynx1 Capital Management LP are GHRS, CGEM, STOK. The fund has invested 41.2% of it's portfolio in GH RESEARCH PLC and 18.9% of portfolio in CULLINAN THERAPEUTICS INC. <br><br> The fund managers got completely rid off DESIGN THERAPEUTICS INC (DSGN) and IBIO INC (IBIO) stocks. They significantly reduced their stock positions in DENALI THERAPEUTICS INC (DNLI), XENCOR INC (XNCR) and IMMATICS N.V (IMTX). Lynx1 Capital Management LP opened new stock positions in PLIANT THERAPEUTICS INC (PLRX), FOGHORN THERAPEUTICS INC (FHTX) and AVALO THERAPEUTICS INC (AVTX). The fund showed a lot of confidence in some stocks as they added substantially to TRAWS PHARMA INC (ONTX), PROQR THRAPEUTICS N V (PRQR) and AGIOS PHARMACEUTICALS INC (AGIO).
Lynx1 Capital Management LP Equity Portfolio Value
Last Reported on: 13 Aug, 2026
$865Million
  as of Aug 13, 2026

Lynx1 Capital Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Lynx1 Capital Management LP made a return of 31.32% in the last quarter. In trailing 12 months, it's portfolio return was 140.8%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
pliant therapeutics inc2,049,800
foghorn therapeutics inc300,549
avalo therapeutics inc186,648
nuvation bio inc91,045
eupraxia pharmaceuticals inc66,100
inhibikase therapeutics inc40,600
New stocks bought by Lynx1 Capital Management LP

Additions

Ticker% Inc.
traws pharma inc3,610
proqr thrapeutics n v661
agios pharmaceuticals inc30.53
gh research plc23.23
passage bio inc8.03
c4 therapeutics inc4.68
Additions to existing portfolio by Lynx1 Capital Management LP

Reductions

Ticker% Reduced
denali therapeutics inc-99.38
xencor inc-96.61
immatics n.v-89.29
entrada therapeutics inc-15.63
stoke therapeutics inc-15.22
precision biosciences inc-3.52
cg oncology inc-0.63
Lynx1 Capital Management LP reduced stake in above stock

Sold off

Ticker$ Sold
design therapeutics inc-1,271,650
ibio inc-129,344
Lynx1 Capital Management LP got rid off the above stocks

Sector Distribution

Lynx1 Capital Management LP has about 55.6% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare55.6
Others44.4

Market Cap. Distribution

Lynx1 Capital Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • SMALL-CAP
  • MID-CAP
  • MICRO-CAP
Category%
UNALLOCATED44.4
SMALL-CAP38.3
MID-CAP14.7
MICRO-CAP2.3

Stocks belong to which Index?

About 49.2% of the stocks held by Lynx1 Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others50.8
RUSSELL 200049.2
Top 5 Winners (%)%
ABSI
absci corporation
286.3 %
GHRS
gh research plc
76.0 %
CCCC
c4 therapeutics inc
74.5 %
DTIL
precision biosciences inc
42.1 %
CGEM
cullinan therapeutics inc
28.1 %
Top 5 Winners ($)$
GHRS
gh research plc
154.0 M
CGEM
cullinan therapeutics inc
35.9 M
CCCC
c4 therapeutics inc
14.6 M
AGIO
agios pharmaceuticals inc
9.9 M
DNLI
denali therapeutics inc
6.2 M
Top 5 Losers (%)%
HOWL
werewolf therapeutics inc
-56.8 %
TRDA
entrada therapeutics inc
-38.4 %
ONTX
traws pharma inc
-37.5 %
PASG
passage bio inc
-37.0 %
BOLT
bolt biotherapeutics inc
-4.7 %
Top 5 Losers ($)$
PASG
passage bio inc
-1.9 M
TRDA
entrada therapeutics inc
-1.0 M
HOWL
werewolf therapeutics inc
-0.3 M
ONTX
traws pharma inc
-0.3 M
TCRX
tscan therapeutics inc
-0.2 M

Lynx1 Capital Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Lynx1 Capital Management LP

Lynx1 Capital Management LP has 27 stocks in it's portfolio. About 98.8% of the portfolio is in top 10 stocks. PASG proved to be the most loss making stock for the portfolio. GHRS was the most profitable stock for Lynx1 Capital Management LP last quarter.

$865.53MTotal Value
29.00Positions
13 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Lynx1 Capital Management LP, last reported on 13 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
GHRS
Gh Research Plc

Gh Research Plc

GHRS
Lynx1 Capital Management LP's holding in Gh Research Plc over time
41.19%13,263,300
$356.52M
41.19%
increased 23.23 percentadded
IMTX
Immatics N.V

Immatics N.V

IMTX
Lynx1 Capital Management LP's holding in Immatics N.V over time
0.03%23,236
$235.4K
0.03%
decreased 89.29 percentreduced
PRQR
Proqr Thrapeutics N V

Proqr Thrapeutics N V

PRQR
Lynx1 Capital Management LP's holding in Proqr Thrapeutics N V over time
0.11%521,413
$969.8K
0.11%
increased 661.34 percentadded